Literature DB >> 27372745

Lymph node ratio predicts survival in hypopharyngeal cancer with positive lymph node metastasis.

Hidenori Suzuki1, Takuma Matoba2, Nobuhiro Hanai2, Daisuke Nishikawa2, Yujiro Fukuda2, Yusuke Koide2, Yasuhisa Hasegawa2.   

Abstract

The lymph node density (LND) has been reported to be a significant prognostic factor in various types of carcinoma. This study investigated whether the LND is associated with survival in patients with hypopharyngeal squamous cell carcinoma (HPSCC) who have positive lymph nodes without distant metastasis. Forty-six patients who were pathologically diagnosed with HPSCC with positive lymph nodes and without distant metastasis were enrolled in this study. The LND was defined as the ratio of positive lymph nodes to the total number of lymph nodes. An LND of ≥0.09 was found to be significantly correlated with a shorter overall (p = 0.044) and disease-specific (p = 0.019) survival according to a log-rank test. In a multivariate survival analysis using a Cox proportional hazards model adjusted for the pathological T category (pT3-4/pT1-2), pathological N category (pN2/pN1) and positive surgical margin and/or extracapsular spread (presence/absence), both an LND of ≥0.09 and pT3-4 category were associated with significantly shorter overall survival (p < 0.01) and disease-specific survival (p < 0.01). These results suggest that the LND functions as a prognostic factor for HPSCC patients with positive lymph nodes who do not have distant metastasis.

Entities:  

Keywords:  Disease-specific survival; Hypopharyngeal squamous cell carcinoma; Lymph node density; Overall survival; Positive lymph nodes

Mesh:

Year:  2016        PMID: 27372745     DOI: 10.1007/s00405-016-4170-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  13 in total

1.  Lymph node density is a prognostic factor in patients with major salivary gland carcinoma.

Authors:  Hidenori Suzuki; Nobuhiro Hanai; Hitoshi Hirakawa; Daisuke Nishikawa; Yasuhisa Hasegawa
Journal:  Oncol Lett       Date:  2015-10-19       Impact factor: 2.967

2.  FDG-PET prediction of head and neck squamous cell cancer outcomes.

Authors:  David L Schwartz; Joseph Rajendran; Bevan Yueh; Marc D Coltrera; Michael Leblanc; Janet Eary; Kenneth Krohn
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-12

3.  Effect of number and ratio of positive lymph nodes in hypopharyngeal cancer.

Authors:  Yong-hong Hua; Qiao-ying Hu; Yong-feng Piao; Qiu Tang; Zhen-fu Fu
Journal:  Head Neck       Date:  2014-03-10       Impact factor: 3.147

4.  Update on the classification and nomenclature system for neck dissection: revisions proposed by the Japan Neck Dissection Study Group.

Authors:  Yasuhisa Hasegawa; Masahisa Saikawa
Journal:  Int J Clin Oncol       Date:  2010-01-27       Impact factor: 3.402

5.  Prognostic Significance of Lymph Node Density in Patients with Hypopharyngeal Squamous Cell Carcinoma.

Authors:  Young-Hoon Joo; Kwang-Jae Cho; Sang-Yeon Kim; Min-Sik Kim
Journal:  Ann Surg Oncol       Date:  2015-07-16       Impact factor: 5.344

6.  Lymph node density predicts lung metastases in oral squamous cell carcinoma.

Authors:  H Suzuki; S Beppu; N Hanai; H Hirakawa; Y Hasegawa
Journal:  Br J Oral Maxillofac Surg       Date:  2015-12-02       Impact factor: 1.651

7.  Prognostic value of (18)F-fluorodeoxyglucose uptake before treatment for pharyngeal cancer.

Authors:  Hidenori Suzuki; Katsuhiko Kato; Yasushi Fujimoto; Yoshiyuki Itoh; Mariko Hiramatsu; Shinji Naganawa; Yasuhisa Hasegawa; Tsutomu Nakashima
Journal:  Ann Nucl Med       Date:  2014-02-11       Impact factor: 2.668

8.  The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.

Authors:  Angela van Baardwijk; Christophe Dooms; Robert Jan van Suylen; Erik Verbeken; Monique Hochstenbag; Cary Dehing-Oberije; Dennis Rupa; Silvia Pastorekova; Sigrid Stroobants; Ulrich Buell; Philippe Lambin; Johan Vansteenkiste; Dirk De Ruysscher
Journal:  Eur J Cancer       Date:  2007-05-23       Impact factor: 9.162

9.  Impact of lymph node ratio on the survival of patients with hypopharyngeal squamous cell carcinoma: a population-based analysis.

Authors:  Yu-Long Wang; Shou-Hao Feng; Ji Zhu; Guo-Pei Zhu; Duan-Shu Li; Yu Wang; Yong-Xue Zhu; Guo-Hua Sun; Qing-Hai Ji
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

10.  Lymph node density in oral cavity cancer: results of the International Consortium for Outcomes Research.

Authors:  S G Patel; M Amit; T C Yen; C T Liao; P Chaturvedi; J P Agarwal; L P Kowalski; A Ebrahimi; J R Clark; C R Cernea; S J Brandao; M Kreppel; J Zöller; D Fliss; E Fridman; G Bachar; T Shpitzer; V A Bolzoni; P R Patel; S Jonnalagadda; K T Robbins; J P Shah; Z Gil
Journal:  Br J Cancer       Date:  2013-09-24       Impact factor: 7.640

View more
  10 in total

1.  Metastatic lymph node burden predictive of survival in patients undergoing primary surgery for laryngeal and hypopharyngeal cancer.

Authors:  Yeonjoo Choi; Manal Bin-Manie; Jong-Lyel Roh; Kyung-Ja Cho; Yoon Se Lee; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2019-07-27       Impact factor: 4.553

2.  Lymph node density in papillary thyroid carcinoma is a prognostic factor after adjusting for pathological stage.

Authors:  Hidenori Suzuki; Yusuke Koide; Nobuhiro Hanai; Daisuke Nishikawa; Shintaro Beppu; Shinji Mikami; Yasuhisa Hasegawa
Journal:  Oncotarget       Date:  2018-06-01

3.  Prognostic significance of lymph node yield and lymph node ratio in patients affected by squamous cell carcinoma of the oral cavity and oropharynx: Study protocol for a prospective, multicenter, observational study.

Authors:  Oreste Iocca; Alessio Farcomeni; Armando De Virgilio; Pasquale Di Maio; Paweł Golusinski; Luca Malvezzi; Raul Pellini; Wojciech Golusinski; Christopher H Rassekh; Giuseppe Spriano
Journal:  Contemp Clin Trials Commun       Date:  2019-01-14

4.  The Prognostic Significance of Lymph Node Ratio and Log Odds Ratio in Laryngeal Squamous Cell Carcinoma.

Authors:  Xinrui Zhang; Feng Yu; Zheng Zhao; Junhao Mai; Yibo Zhou; Guojie Tan; Xuekui Liu
Journal:  OTO Open       Date:  2018-09-27

5.  Prognostic value of lymph node ratio in laryngeal and hypopharyngeal squamous cell carcinoma: a systematic review and meta-analysis.

Authors:  Arikin Abdeyrim; Shizhi He; Yang Zhang; Gulbostan Mamtali; Aibadla Asla; Mirkamil Yusup; Jiang Liu
Journal:  J Otolaryngol Head Neck Surg       Date:  2020-05-29

6.  Lymph node ratio as a predictor for minor salivary gland cancer in head and neck.

Authors:  Hidenori Suzuki; Eiichi Sasaki; Gaku Takano; Seiya Goto; Daisuke Nishikawa; Shintaro Beppu; Hoshino Terada; Michi Sawabe; Nobuhiro Hanai
Journal:  BMC Cancer       Date:  2021-11-06       Impact factor: 4.430

7.  Positive lymph node ratio predicts adverse prognosis for patients with lymph nodes metastatic hypopharyngeal squamous cell carcinoma after primary surgery.

Authors:  Ke Wang; Wendong Tian; Xia Xu; Xiaohong Peng; Haocheng Tang; Yunteng Zhao; Xianwen Wang; Gang Li
Journal:  Transl Cancer Res       Date:  2022-03       Impact factor: 1.241

8.  RBM24 Mediates Lymph Node Metastasis and Epithelial-Mesenchymal Transition in Human Hypopharyngeal Squamous Cell Carcinoma by Regulating Twist1.

Authors:  Yuhong Liu; Min Pan; Tao Lu; Yanshi Li; Dan Yu; Zhihai Wang; Guohua Hu
Journal:  J Oncol       Date:  2022-09-29       Impact factor: 4.501

9.  Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".

Authors:  Lars Schüttrumpf; Sebastian Marschner; Katrin Scheu; Julia Hess; Sibylle Rietzler; Axel Walch; Philipp Baumeister; Thomas Kirchner; Ute Ganswindt; Horst Zitzelsberger; Claus Belka; Cornelius Maihoefer
Journal:  Radiat Oncol       Date:  2020-01-06       Impact factor: 3.481

10.  Prognostic Value of Lymph Node Density in Patients With T3 and T4 Pyriform Sinus Carcinoma.

Authors:  Lifeng Jia; Jingya Li; Ziyuan Zhou; Wei Yuan
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.